Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Monika Bratová"'
Autor:
Kristian Brat, Monika Bratova, Jana Skrickova, Magda Barinova, Karolina Hurdalkova, Milos Pesek, Libor Havel, Leona Koubkova, Michal Hrnciarik, Jana Krejci, Ondrej Fischer, Milada Zemanova, Helena Coupkova, Martin Svaton
Publikováno v:
Thoracic Cancer, Vol 11, Iss 11, Pp 3346-3356 (2020)
Background Data regarding real‐life effectiveness of any treatment may improve clinical decision‐making. The aim of this study was to evaluate real‐life effectiveness of tyrosin‐kinase inhibitors, bevacizumab and pemetrexed as first‐line tr
Externí odkaz:
https://doaj.org/article/cbc351e845594ab6848729e0cc8a090b
Autor:
Andrej Mazur, Kristian Brat, Pavel Homolka, Zdenek Merta, Michal Svoboda, Monika Bratova, Vladimir Sramek, Lyle J Olson, Ivan Cundrle
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0272984 (2022)
IntroductionVentilatory efficiency (VE/VCO2 slope) has been shown superior to peak oxygen consumption (VO2) for prediction of post-operative pulmonary complications in patients undergoing thoracotomy. VE/VCO2 slope is determined by ventilatory drive
Externí odkaz:
https://doaj.org/article/3aeae37e4e9042559c4ceb679770ccdd
Autor:
Monika Bratová
Publikováno v:
Onkologie. 17:8-11
Autor:
Leona Koubková, Monika Bratová, Kristián Brat, Martin Svaton, Marie Drosslerova, Jana Krejčí, Juraj Kultan, Magda Barinova, Matyas Wanke, Karolina Hurdalkova
Publikováno v:
Journal of Adolescent and Young Adult Oncology. 11:451-458
Purpose: Aim was to analyze demographic and tumor characteristics, treatment, and survival of patients with lung cancer younger than 40 years of age (U40) compared to older subgroups (41–70 and >70...
Prognostic Value ofEGFRExon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer
Autor:
Marketa Cernovska, Leona Koubková, Kristina Sandstrom, Jana Krejčí, Martin Svaton, Monika Bratová, Jiri Blazek, Jana Skrickova, P. Opálka, Helena Čoupková, Michal Hrnčiarik, Ondrej Fischer, Karolina Hurdalkova, Daniel Dolezal, Tana Tuzova, Magda Barinova, Milada Zemanova, Péter Kunovszki, Lubos Holubec, Miloš Pešek, P. Mahadevia
Publikováno v:
Anticancer Research. 41:5625-5634
Background/aim Per literature, patients with epidermal growth factor receptor (EGFR) exon-20 insertions respond poorly to tyrosine kinase inhibitors (TKIs). This study analyzed real-world data to examine the prognostic and predictive value of these m
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 35(3)
The pandemic of COVID-19 has significantly influenced the dia-gnostics and treatment of patients with lung and pleural malignancies. This group of patients is the riskiest, compared to patients with other cancers, both in morbidity and mortality.The
Publikováno v:
Vnitřní lékařství. 67:175-179
Pembrolizumab belongs to so called immune checkpoint inhibitors. Frequent adverse event of this therapy is hypothyroidism. The authors present a case report of patient treated with pembrolizumab for non-small cell lung carcinoma, in whom severe hypot
Autor:
Magda Barinova, Jana Skrickova, P. Opálka, Miloš Pešek, M. Černovská, Martin Safanda, Karolina Hurdalkova, Helena Coupkova, Martin Svaton, Daniel Krejci, Milada Zemanova, Monika Bratová, Michal Hrnčiarik, Daniel Dolezal, J. Krejčí, Petra Zemanova, Leona Koubková, Juraj Kultan, Ondrej Fischer
Publikováno v:
Anticancer Research. 41:2597-2603
Background/aim Platinum-based chemotherapy with pemetrexed or paclitaxel/bevacizumab are regimens used in combination with checkpoint inhibitors in non-squamous non-small cell lung cancer (NSCLC) treatment. We conducted a real-world study to compare
Autor:
Monika Bratová, Daniel Dolezal, Michal Hrnčiarik, Marketa Cernovska, Magda Barinova, Tana Tuzova, Milada Zemanova, Martin Svaton, Ondrej Fischer, Jana Krejčí, Helena Čoupková, Jana Skrickova, Karolina Hurdalkova, Bedrich Porzer, Leona Koubková
Publikováno v:
Anticancer Research. 41:2059-2065
Background/Aim: We investigated efficacy differences for afatinib versus gefitinib in non-small-cell lung cancer (NSCLC) according to epidermal growth factor receptor (EGFR) mutations. Patients and Methods: We retrospectively analysed data for 343 pa
Autor:
Martin Svaton, Kristián Brat, Libor Havel, Magda Barinova, Leona Koubková, Helena Čoupková, Jana Skrickova, Ondrej Fischer, Michal Hrnčiarik, Karolina Hurdalkova, Milada Zemanova, Jana Krejčí, Monika Bratová, Miloš Pešek
Publikováno v:
Thoracic Cancer, Vol 11, Iss 11, Pp 3346-3356 (2020)
Thoracic Cancer
Thoracic Cancer
Background Data regarding real‐life effectiveness of any treatment may improve clinical decision‐making. The aim of this study was to evaluate real‐life effectiveness of tyrosin‐kinase inhibitors, bevacizumab and pemetrexed as first‐line tr